1. Home
  2. EGY vs NMRA Comparison

EGY vs NMRA Comparison

Compare EGY & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EGY
  • NMRA
  • Stock Information
  • Founded
  • EGY 1985
  • NMRA 2019
  • Country
  • EGY United States
  • NMRA United States
  • Employees
  • EGY N/A
  • NMRA N/A
  • Industry
  • EGY Oil & Gas Production
  • NMRA
  • Sector
  • EGY Energy
  • NMRA
  • Exchange
  • EGY Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • EGY 340.3M
  • NMRA 287.6M
  • IPO Year
  • EGY N/A
  • NMRA 2023
  • Fundamental
  • Price
  • EGY $3.48
  • NMRA $0.65
  • Analyst Decision
  • EGY Strong Buy
  • NMRA Buy
  • Analyst Count
  • EGY 1
  • NMRA 8
  • Target Price
  • EGY $8.00
  • NMRA $9.29
  • AVG Volume (30 Days)
  • EGY 1.2M
  • NMRA 1.2M
  • Earning Date
  • EGY 05-06-2025
  • NMRA 05-06-2025
  • Dividend Yield
  • EGY 7.17%
  • NMRA N/A
  • EPS Growth
  • EGY N/A
  • NMRA N/A
  • EPS
  • EGY 0.56
  • NMRA N/A
  • Revenue
  • EGY $478,988,000.00
  • NMRA N/A
  • Revenue This Year
  • EGY N/A
  • NMRA N/A
  • Revenue Next Year
  • EGY $23.00
  • NMRA N/A
  • P/E Ratio
  • EGY $6.24
  • NMRA N/A
  • Revenue Growth
  • EGY 5.26
  • NMRA N/A
  • 52 Week Low
  • EGY $3.00
  • NMRA $0.62
  • 52 Week High
  • EGY $7.43
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • EGY 46.12
  • NMRA 22.34
  • Support Level
  • EGY $3.22
  • NMRA $0.64
  • Resistance Level
  • EGY $3.44
  • NMRA $0.83
  • Average True Range (ATR)
  • EGY 0.22
  • NMRA 0.09
  • MACD
  • EGY 0.01
  • NMRA 0.02
  • Stochastic Oscillator
  • EGY 56.47
  • NMRA 6.68

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: